Filing Details

Accession Number:
0001567619-19-022780
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-09 16:51:39
Reporting Period:
2019-12-05
Accepted Time:
2019-12-09 16:51:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827809 Novelion Therapeutics Inc. NVLNF Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1370042 Stonepine Capital, L.p. 919 Nw Bond Street, Suite 204
Bend OR 97703
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-05 5,160 $0.70 3,898,425 No 4 P Direct
Common Stock Acquisiton 2019-12-06 40 $0.70 3,898,465 No 4 P Direct
Common Stock Acquisiton 2019-12-09 4,500 $0.70 3,902,965 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct